Farxiga is available in both brand-name and generic forms (generic dapagliflozin launched in 2024), whereas semaglutide (Ozempic) is only available as a brand-name medication with no generic option
Cardiovascular support: It has been demonstrated that cardiovascular support can reduce the symptoms of heart conditions like angina and heart failure
GLP-1 & GIP therapy is administered via subcutaneous injection once per week a convenient schedule that supports adherence compared to daily medications
Changes in morbid adipose tissue in endocrine characteristics could decrease adiponectin secretion, which is an insulin enhancer ( Metabolomics revealed that APS could strengthen ISI by upregulating the mi-RNA transducer of ErbB2.2, TMEM100, and the ubiquitin-specific proteases (USP15) (Pan et al., 2019
High-dose vitamin C requires caution in people with kidney disease, G6PD deficiency, or a history of kidney stones because large IV doses increase oxalate load